Zantac Pancreatic Cancer: Qualifying For A Lawsuit

Zantac Pancreatic Cancer

Important Announcement: Zantac and its generic form ranitidine have had a market recall request from the FDA. Zantac can break down into the chemical NDMA, which may cause various forms of cancer, including pancreatic cancer. The FDA strongly recommends that all Zantac and ranitidine products be disposed of safely. If you have had a cancer diagnosis after taking ranitidine, you may be entitled to compensation.

If you think you may qualify to file a Zantac lawsuit, fill out our pre-qualification form or keep reading to learn more.

The NDMA Carcinogen

On April 1, 2020, the FDA requested that Zantac be recalled from the market. Their ongoing research points to the fact that ranitidine medications break down into N-Nitrosodimethylamine (NDMA), a known contaminant and carcinogen.

NDMA forms in Zantac while in the packaging after prolonged periods of time or under high temperatures.

Not only can NDMA be formed within the package, but it is likely also formed when ranitidine is being broken down by the body in the stomach.

The FDA suggests that the general public should use alternatives to Zantac that are not ranitidine-based medications.

Signs of Pancreatic Cancer

If you are showing unusual symptoms and take Zantac on a frequent basis, it is important to get a cancer screening from a doctor.

Symptoms that may be signs of pancreatic cancer include:

  • Yellowing of the eyes and skin (Jaundice)
  • Unexpected weight loss
  • Back or stomach pain
  • Loss of appetite
  • Light-colored or fatty stool
  • Painful blood clots swelling, usually in the leg

If you have a pancreatic cancer diagnosis and have used Zantac or another ranitidine-based drug for a prolonged period of time, you may be entitled to compensation.

Zantac and Pancreatic Cancer

Generally speaking, you must meet a few qualifications before you can file a lawsuit for damages caused by Zantac.

In general adult cases, you need to prove at least 1 year of use prior to a cancer diagnosis. The consumed amount is a minimum of 300 mg/week during a 1-year period of use. There is also a statute of limitation that no more than 10 years has passed since the last use of Zantac prior to your cancer diagnosis.

If you are a woman who took Zantac during pregnancy, you may fall under the stipulations of prenatal exposure cases. This means you took Zantac for at least 6 months during pregnancy. A minimum of 300 mg/week must have been taken, and there can be no more than 5 years after birth until diagnosis of the pancreatic cancer.

For cases involving children, there are separate rules for pediatric exposure cases. Usage must involve at least 1 year of use prior to a cancer diagnosis. A minimum of 150 mg/week must have been taken, with no more than 1 year since the last use prior to a cancer diagnosis.

These are not the only qualifications that may apply, and special circumstances may also apply. Please contact us for more information.

Other Cancers That May Be Linked to Zantac Usage

Pancreatic cancer is unfortunately just one of the types of cancer that may be caused by frequent use of Zantac.

Some other forms of cancer that Zantac may cause are:

  • Kidney
  • Stomach
  • Intestinal
  • Bladder
  • Lung
  • Colorectal
  • Thyroid

Contact VanDerGinst Law to See If You Qualify for Compensation

If you have been diagnosed with pancreatic cancer or any of the other forms listed above, we strongly suggest you reach out to see if you qualify to file a Zantac lawsuit with us.

You may be entitled to compensation if you meet the above requirements, and we would highly recommend working with a personal injury lawyer during this complex process.

The experienced and knowledgeable personal injury attorneys at VanDerGinst Law can help you make sense of your case and work to get you the compensation you deserve.

Call us at 800-797-5391 if you would prefer to discuss your case over the phone.

The law is tough, being injured is tougher.

We’ll make it easier for you.

See Other Related Articles